Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
New words:
atezolizumab, biliary, billion, booster, deadline, exon, Foundation, FoundationOne®CDx, inclusion, macroeconomic, raw, Society, tied, tract, truncation, unconditional
Removed:
deducting, predominantly, prioritized, settlement, unclear
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view